CH453351A - Procédé de préparation de stéroïdes - Google Patents

Procédé de préparation de stéroïdes

Info

Publication number
CH453351A
CH453351A CH584766A CH584766A CH453351A CH 453351 A CH453351 A CH 453351A CH 584766 A CH584766 A CH 584766A CH 584766 A CH584766 A CH 584766A CH 453351 A CH453351 A CH 453351A
Authority
CH
Switzerland
Prior art keywords
steroids
preparation
Prior art date
Application number
CH584766A
Other languages
English (en)
French (fr)
Inventor
Giacomo Nathansohn Gian
Winters Giorgio
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of CH453351A publication Critical patent/CH453351A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/0025Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16
    • C07J7/0035Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa substituted in position 16 by a hydroxy group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0057Nitrogen and oxygen
    • C07J71/0068Nitrogen and oxygen at position 16(17)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Agricultural Machines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH584766A 1965-04-22 1966-04-22 Procédé de préparation de stéroïdes CH453351A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB17027/65A GB1077392A (en) 1965-04-22 1965-04-22 New steroids
GB3586565 1965-08-20

Publications (1)

Publication Number Publication Date
CH453351A true CH453351A (fr) 1968-06-14

Family

ID=26252388

Family Applications (2)

Application Number Title Priority Date Filing Date
CH584666A CH471833A (fr) 1965-04-22 1966-04-22 Procédé de préparation de stéroïdes-oxazolines
CH584766A CH453351A (fr) 1965-04-22 1966-04-22 Procédé de préparation de stéroïdes

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH584666A CH471833A (fr) 1965-04-22 1966-04-22 Procédé de préparation de stéroïdes-oxazolines

Country Status (15)

Country Link
US (2) US3436389A (de)
AT (2) AT260440B (de)
BE (2) BE679821A (de)
BR (2) BR6678805D0 (de)
CH (2) CH471833A (de)
DE (3) DE1568950A1 (de)
DK (2) DK116870B (de)
ES (1) ES325755A1 (de)
FI (2) FI44905C (de)
FR (1) FR5645M (de)
GB (1) GB1077392A (de)
IL (2) IL25494A (de)
NL (3) NL6605174A (de)
NO (2) NO127346B (de)
SE (2) SE323675B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1119081A (en) * 1966-01-11 1968-07-10 Lepetit Spa New steroids
IT1141930B (it) * 1980-04-28 1986-10-08 Lepetit Spa Esteri idrosolubili di steroido-ossazoli e loro composizioni farmaceutiche
IT1134455B (it) * 1980-11-26 1986-08-13 Lepetit Spa Procedimento per la preparazione di derivati 16alfa-idrossi-17alfa-aminopregnanici
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
EP1694655A2 (de) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesteraseinhibitoren
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
EP1948167A1 (de) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Zusammensetzungen von phosphodiesterase-typ-iv-hemmern
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
CN101177443B (zh) * 2006-11-09 2011-08-03 天津药业研究院有限公司 新的甾体化合物及其应用
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
MX2009009793A (es) * 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (de) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Zusammensetzungen von Phosphodiesterase-IV-Hemmern

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2874154A (en) * 1954-10-15 1959-02-17 Syntex Sa Process for the production of 20-keto-21-iodo steroids
US2923721A (en) * 1955-12-13 1960-02-02 Lab Francais Chimiotherapie Method of preparing 3-keto delta1, 4 steroids
DE1223376B (de) * 1963-12-14 1966-08-25 Hoechst Ag Verfahren zur Herstellung von 17alpha-Cyan-16alpha-hydroxy-steroiden der Pregnanreihe
US3349084A (en) * 1965-05-17 1967-10-24 Upjohn Co Steroidal [16, 17-d]-2'-isoxazolines of the pregnane series

Also Published As

Publication number Publication date
NO128152B (de) 1973-10-08
AT265539B (de) 1968-10-10
DK117631B (da) 1970-05-19
GB1077392A (en) 1967-07-26
FI44906C (fi) 1972-02-10
IL25494A (en) 1970-03-22
IL25493A (en) 1969-12-31
SE323675B (de) 1970-05-11
DE1793662C3 (de) 1973-11-08
AT260440B (de) 1968-03-11
DK116870B (da) 1970-02-23
DE1568950A1 (de) 1970-11-26
DE1793662A1 (de) 1972-08-03
NL6605375A (de) 1966-10-24
SE323674B (de) 1970-05-11
FI44906B (de) 1971-11-01
DE1568951A1 (de) 1970-06-18
NL128816C (de)
CH471833A (fr) 1969-04-30
ES325755A1 (es) 1967-02-16
NL6605174A (de) 1966-10-24
BR6679615D0 (pt) 1973-10-23
US3413286A (en) 1968-11-26
BE679820A (de) 1966-10-03
FR5645M (de) 1967-12-26
NO127346B (de) 1973-06-12
DE1793662B2 (de) 1973-04-19
BR6678805D0 (pt) 1973-09-18
BE679821A (de) 1966-10-03
FI44905B (de) 1971-11-01
FI44905C (fi) 1972-02-10
US3436389A (en) 1969-04-01

Similar Documents

Publication Publication Date Title
CH453351A (fr) Procédé de préparation de stéroïdes
CH468412A (fr) Procédé de préparation de chlordialcoylthiophosphates
FR89870E (fr) Procédé de préparation de nu-vinyl-amides
FR1515015A (fr) Procédé de préparation de poly-n-oxydes
CH507227A (fr) Procédé de préparation de stéroïdes
CH452518A (fr) Procédé de préparation de 17a-acyloxy-11B-hydroxystéroïdes
CH458320A (fr) Procédé de préparation du d-camphorate de 1-carnitinamide
CH491895A (fr) Procédé de préparation de stéroïdes
CH487137A (fr) Procédé de préparation de sapogénines stéroïdes
FR1455825A (fr) Procédé de préparation de phényl-tétrahydropyridines substituées
FR1510206A (fr) Procédé de préparation de diaza-cyclo-alcanes substitués
FR1506008A (fr) Procédé de préparation de stéroïdes
CH462808A (fr) Procédé de préparation de stéroïdes
FR1476607A (fr) Procédé de préparation de 17alpha-alcoyl stéroïdes
CH432515A (fr) Procédé de préparation de stéroïdes
FR1498560A (fr) Procédé de préparation de 17-cétostéroïdes
CH468370A (fr) Procédé de préparation de stéroïdes
CH483414A (fr) Procédé de préparation de stéroïdes
FR1505675A (fr) Procédé de préparation de 6alpha-fluoro-16-méthylène-stéroïdes
FR1501017A (fr) Procédé pour la préparation de stéroïdes
CH487878A (fr) Procédé de préparation de stéroïdes
CH506509A (fr) Procédé de préparation de stéroïdes
FR1505353A (fr) Procédé de préparation de 17alpha-hydroxy-16, 20-dioxo stéroïdes
FR1544536A (fr) Procédé de préparation de stéroïdes
FR1514015A (fr) Procédé de préparation de méthyl-10beta-hydroxy-11beta-alcoyl-13 stéroïdes